A randomized clinical trial of Cisplatin/Paclitaxel versus Carboplatin/Paclitaxel as first-line treatment of ovarian cancer. - Du Bois,A.; Lück,H.J.; Meier,W.; Adams,H.P.; Möbus,V.; Costa,S.; Bauknecht,T.; Richter,B.; Warm,M.; Schröder,W.; Olbricht,S.; Nitz,U.; et al. (J Natl Cancer Inst, 2003)